XML 13 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated other comprehensive loss
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2022 $ 329,926 $ 4 $ 643,774 $ (3,585) $ (310,267)
Beginning balance, Shares at Dec. 31, 2022   43,749,685      
Share-based compensation 5,963   5,963    
Issuance of common stock upon exercise of stock options 57   57    
Issuance of common stock upon exercise of stock options, Shares   47,328      
Issuance of common stock upon release of restricted stock units, Shares   215,505      
Shares withheld for the withholding tax on vesting of restricted stock (20)   (20)    
Shares withheld for the withholding tax on vesting of restricted stock, Shares   (2,499)      
Unrealized gain (loss) on available-for-sale securities 1,212     1,212  
Net Income (Loss) (35,174)       (35,174)
Ending balance at Mar. 31, 2023 301,964 $ 4 649,774 (2,373) (345,441)
Ending balance, Shares at Mar. 31, 2023   44,010,019      
Beginning balance at Dec. 31, 2023 228,442 $ 5 688,124 (87) (459,600)
Beginning balance, Shares at Dec. 31, 2023   52,388,961      
Share-based compensation 5,261   5,261    
Issuance of common stock upon exercise of stock options $ 39   39    
Issuance of common stock upon exercise of stock options, Shares 28,227 28,227      
Issuance of common stock upon release of restricted stock units, Shares   423,869      
Shares withheld for the withholding tax on vesting of restricted stock $ (55)   (55)    
Shares withheld for the withholding tax on vesting of restricted stock, Shares   (25,286)      
Unrealized gain (loss) on available-for-sale securities (161)     (161)  
Net Income (Loss) (35,326)       (35,326)
Ending balance at Mar. 31, 2024 $ 198,200 $ 5 $ 693,369 $ (248) $ (494,926)
Ending balance, Shares at Mar. 31, 2024   52,815,771